Skip to main content

Neurogene Inc.

NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404644

In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 2 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.

13F holders, Q3 2023

Institutional positions in Neurogene Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
31
−5 vs. Q2 2023
Shares held
3.65M
+192.5K (+5.6%) vs. Q2 2023Converted for a 1-for-5 split
Total value
$14.4M
+$72.2K (+0.5%) vs. Q2 2023
New holders
5
7 more added
Sold out
10
8 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NGNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 31 institutions
Q1 2021: 82 institutionsQ2 2021: 82 institutionsQ3 2021: 85 institutionsQ4 2021: 80 institutionsQ1 2022: 81 institutionsQ2 2022: 64 institutionsQ3 2022: 52 institutionsQ4 2022: 46 institutionsQ1 2023: 39 institutionsQ2 2023: 36 institutionsQ3 2023: 31 institutionsQ4 2023: 35 institutionsQ1 2024: 60 institutionsQ2 2024: 66 institutionsQ3 2024: 86 institutionsQ4 2024: 89 institutionsQ1 2025: 86 institutionsQ2 2025: 83 institutionsQ3 2025: 88 institutionsQ4 2025: 93 institutionsQ1 2026: 96 institutionsQ2 2026: 111 institutions
Value heldQ3 2023: $14.4M
Q1 2021: $341.9MQ2 2021: $248.8MQ3 2021: $187.1MQ4 2021: $118.8MQ1 2022: $46.3MQ2 2022: $21.4MQ3 2022: $12.0MQ4 2022: $8.66MQ1 2023: $10.5MQ2 2023: $14.3MQ3 2023: $14.4MQ4 2023: $179.0MQ1 2024: $617.3MQ2 2024: $482.7MQ3 2024: $581.1MQ4 2024: $367.8MQ1 2025: $192.8MQ2 2025: $230.1MQ3 2025: $265.2MQ4 2025: $340.4MQ1 2026: $342.0MQ2 2026: $544.4M
Institutions holding NGNE and their total value by quarter
QuarterHoldersValue
Q2 2026111$544.4M
Q1 202696$342.0M
Q4 202593$340.4M
Q3 202588$265.2M
Q2 202583$230.1M
Q1 202586$192.8M
Q4 202489$367.8M
Q3 202486$581.1M
Q2 202466$482.7M
Q1 202460$617.3M
Q4 202335$179.0M
Q3 202331$14.4M
Q2 202336$14.3M
Q1 202339$10.5M
Q4 202246$8.66M
Q3 202252$12.0M
Q2 202264$21.4M
Q1 202281$46.3M
Q4 202180$118.8M
Q3 202185$187.1M
Q2 202182$248.8M
Q1 202182$341.9M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Neurogene Inc.; share changes are against Q2 2023.

Institutions holding NGNE in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Baker Bros. Advisors LP1,221,414$4.82M0.03%+457,066+59.8%AddedConverted for a 1-for-5 split
Redmile Group, LLC582,443$2.30M0.11%00.0%UnchangedConverted for a 1-for-5 split
Adage Capital Partners GP, L.L.C.310,000$1.22M0.00%+310,000New
Nantahala Capital Management, LLC299,999$1.18M0.15%+299,999New
Bank of America Corp231,779$915.5K0.00%00.0%UnchangedConverted for a 1-for-5 split
Vanguard Group Inc201,539$796.1K0.00%00.0%UnchangedConverted for a 1-for-5 split
Renaissance Technologies LLC163,447$646.0K0.00%−23,998−12.8%ReducedConverted for a 1-for-5 split
Morgan Stanley107,671$425.3K0.00%−56,723−34.5%ReducedConverted for a 1-for-5 split
BML Capital Management, LLC98,664$389.7K0.36%+93,914+1,977.2%AddedConverted for a 1-for-5 split
BlackRock Inc.96,613$381.6K0.00%00.0%UnchangedConverted for a 1-for-5 split
Geode Capital Management, LLC62,885$248.5K0.00%+2,674+4.4%AddedConverted for a 1-for-5 split
Millennium Management LLC37,756$149.1K0.00%−84,174−69.0%ReducedConverted for a 1-for-5 split
Two Sigma Investments, LP34,206$135.1K0.00%−8,033−19.0%ReducedConverted for a 1-for-5 split
Two Sigma Advisers, LP33,880$133.8K0.00%−3,020−8.2%ReducedConverted for a 1-for-5 split
Point72 Asset Management, L.P.27,335$108.0K0.00%00.0%UnchangedConverted for a 1-for-5 split
CVI Holdings, LLC24,916$98.4K0.20%+24,916New
State Street Corp24,510$96.8K0.00%00.0%UnchangedConverted for a 1-for-5 split
Kynam Capital Management, LP24,037$94.9K0.02%00.0%UnchangedConverted for a 1-for-5 split
Citadel Advisors LLC21,961$86.7K0.00%+12,383+129.3%AddedConverted for a 1-for-5 split
US Bancorp13,869$54.8K0.00%+5,000+56.4%AddedConverted for a 1-for-5 split
Northern Trust Corp13,727$54.2K0.00%−181−1.3%ReducedConverted for a 1-for-5 split
Susquehanna International Group, LLP13,154$52.0K0.00%+13,154New
Wells Fargo & Company1,653$6.53K0.00%00.0%UnchangedConverted for a 1-for-5 split
Tower Research Capital LLC (TRC)823$3.25K0.00%+823New
Group One Trading, L.P.299$1.18K0.00%−2−0.6%ReducedConverted for a 1-for-5 split
UBS Group AG231$9120.00%+11+5.0%AddedConverted for a 1-for-5 split
Farther Finance Advisors, LLC200$7900.00%00.0%UnchangedConverted for a 1-for-5 split
Truvestments Capital LLC185$7310.00%00.0%UnchangedConverted for a 1-for-5 split
Advisor Group Holdings, Inc.100$3950.00%−200−66.7%ReducedConverted for a 1-for-5 split
JPMorgan Chase & Co45$1780.00%+0+0.9%AddedConverted for a 1-for-5 split
National Bank of Canada35$1340.00%00.0%UnchangedConverted for a 1-for-5 split
Lynx1 Capital Management LP0$00.00%−618,911−100.0%Sold outConverted for a 1-for-5 split
Western Standard LLC0$00.00%−172,176−100.0%Sold outConverted for a 1-for-5 split
Privium Fund Management (UK) Ltd0$00.00%−23,440−100.0%Sold outConverted for a 1-for-5 split
Alta Fundamental Advisers LLC0$00.00%−17,940−100.0%Sold outConverted for a 1-for-5 split
HighTower Advisors, LLC0$00.00%−9,682−100.0%Sold outConverted for a 1-for-5 split
Simon Quick Advisors, LLC0$00.00%−4,686−100.0%Sold outConverted for a 1-for-5 split
Bank of New York Mellon Corp0$00.00%−2,874−100.0%Sold outConverted for a 1-for-5 split
Federated Hermes, Inc.0$00.00%−311−100.0%Sold outConverted for a 1-for-5 split
Barclays PLC0$00.00%−33−100.0%Sold outConverted for a 1-for-5 split
Royal Bank of Canada0$00.00%−118−100.0%Sold outConverted for a 1-for-5 split